Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Lopez-Rios

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
The Oncologist|April 28, 2018
Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with TrastuzumabAsunción Díaz-Serrano, Barbara Angulo, Carolina Dominguez, et al.
Lung Cancer (Amsterdam, Netherlands)|June 27, 2026
New biomarkers for antibody-drug conjugates in lung cancer the pathologist's perspectiveVéronique Hofman, Guylène Rignol, Baharia Mograbi, et al.
International Journal of Cancer|February 13, 2013
Determining the profiles and parameters for gene amplification testing of growth factor receptors in lung cancerEva Pros, Sylvie Lantuejoul, Lydia Sanchez-Verde, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2025
Optimizing communication for ultrafast lung cancer biomarker testing: the UTOPIA pilot studySusana Hernandez, Esther Conde, Marta Alonso, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 12, 2025
PD-L1 expression scoring using artificial intelligence algorithms in non-small cell lung cancer harbouring ROS1 fusions: potential clinical-biological significanceLuis Fernando García, Esther Conde, Susana Hernandez, et al.
Histopathology|August 18, 2017
Aligning digital CD8<sup>+</sup> scoring and targeted next-generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early-stage squamous cell lung carcinomaEsther Conde, Alejandra Caminoa, Carolina Dominguez, et al.
Plos One|March 15, 2014
MicroRNA-dependent regulation of transcription in non-small cell lung cancerSonia Molina-Pinelo, Gabriel Gutiérrez, Maria Dolores Pastor, et al.
Archives of Pathology & Laboratory Medicine|April 16, 2024
Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity FoundationLynette M Sholl, Mark Awad, Upal Basu Roy, et al.
Clinical Chemistry|January 12, 2017
Identification of <i>ALK</i>, <i>ROS1</i>, and <i>RET</i> Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer PatientsNoemí Reguart, Cristina Teixidó, Ana Giménez-Capitán, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2022
Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology CommitteeMari Mino-Kenudson, Kurt Schalper, Wendy Cooper, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
The Oncologist|April 28, 2018
Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with TrastuzumabAsunción Díaz-Serrano, Barbara Angulo, Carolina Dominguez, et al.
Lung Cancer (Amsterdam, Netherlands)|June 27, 2026
New biomarkers for antibody-drug conjugates in lung cancer the pathologist's perspectiveVéronique Hofman, Guylène Rignol, Baharia Mograbi, et al.
International Journal of Cancer|February 13, 2013
Determining the profiles and parameters for gene amplification testing of growth factor receptors in lung cancerEva Pros, Sylvie Lantuejoul, Lydia Sanchez-Verde, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2025
Optimizing communication for ultrafast lung cancer biomarker testing: the UTOPIA pilot studySusana Hernandez, Esther Conde, Marta Alonso, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 12, 2025
PD-L1 expression scoring using artificial intelligence algorithms in non-small cell lung cancer harbouring ROS1 fusions: potential clinical-biological significanceLuis Fernando García, Esther Conde, Susana Hernandez, et al.
Histopathology|August 18, 2017
Aligning digital CD8<sup>+</sup> scoring and targeted next-generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early-stage squamous cell lung carcinomaEsther Conde, Alejandra Caminoa, Carolina Dominguez, et al.
Plos One|March 15, 2014
MicroRNA-dependent regulation of transcription in non-small cell lung cancerSonia Molina-Pinelo, Gabriel Gutiérrez, Maria Dolores Pastor, et al.
Archives of Pathology & Laboratory Medicine|April 16, 2024
Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity FoundationLynette M Sholl, Mark Awad, Upal Basu Roy, et al.
Clinical Chemistry|January 12, 2017
Identification of <i>ALK</i>, <i>ROS1</i>, and <i>RET</i> Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer PatientsNoemí Reguart, Cristina Teixidó, Ana Giménez-Capitán, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2022
Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology CommitteeMari Mino-Kenudson, Kurt Schalper, Wendy Cooper, et al.
Pageof 7